Cortical bone area predicts incident fractures independently of areal bone mineral density in older men by Ohlsson, Claes et al.
C L I N I C A L R E S E A R C H A R T I C L E
Cortical Bone Area Predicts Incident Fractures
Independently of Areal Bone Mineral Density
in Older Men
Claes Ohlsson,1* Daniel Sundh,1,2* Andreas Wallerek,1,2 Martin Nilsson,1,2
Magnus Karlsson,3,4 Helena Johansson,1,2,5 Dan Mellstro¨m,1,2
and Mattias Lorentzon1,2
1Center for Bone Research at the Sahlgrenska Academy, Institute of Medicine, and 2Geriatric Medicine,
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg,
413 45 Gothenburg, Sweden; 3Clinical and Molecular Osteoporosis Research Unit, Department of Clinical
Sciences, Lund University, 221 00 Lund, Sweden; 4Department of Orthopaedics, Ska˚ne University Hospital,
205 02 Malmo¨, Sweden; and 5Institute for Health and Ageing, Catholic University of Australia, Melbourne
3000, Australia
Context: Areal bone mineral density (aBMD) measured using dual-energy X-ray absorptiometry
(DXA) is used clinically to predict fracture but does not discriminate between trabecular and cortical
bone assessment.
Objective: This study aimed to investigate whether information on cortical and trabecular bone
predict fracture risk independently of aBMD and clinical risk factors.
Design and Participants: Cortical area, bonemass, porosity, and trabecular bone volume fraction (BVTV)
were measured at the tibia using high-resolution peripheral quantitative computed tomography (HR-
pQCT) in 456 men (80.2 6 3.5 years) recruited from the general population in Gothenburg, Sweden.
aBMD was measured using DXA. Incident fractures (71 men) were X-ray verified. Associations were
evaluated using Cox regression.
Results: Cortical area [hazard ratio (HR) per standard deviation (SD) decrease, 2.05; 95% confidence
interval (CI), 1.58 to 2.65], cortical bone mass (HR, 2.07; 95% CI, 1.58 to 2.70), and BVTV (HR, 1.62;
95% CI, 1.26 to 2.07), but not cortical porosity, were independently associated with fracture risk.
These associations remained after adjustment for femoral neck aBMD and Fracture Risk Assessment
risk factors (area: HR 1.96, 95% CI, 1.44 to 2.66; mass: HR 1.99, 95% CI, 1.45 to 2.74; BV/TV: HR 1.46,
95% CI, 1.09 to 1.96). After entering BV/TV and cortical area or bone mass simultaneously in the
adjusted models, only the cortical parameters remained important predictors of fracture.
Conclusion: HR-pQCT measurement of cortical area and mass might add clinically useful information
for the evaluation of fracture risk. (J Clin Endocrinol Metab 102: 516–524, 2017)
Osteoporosis is a disease characterized by low bonemass and microarchitectural deterioration of bone
tissue leading to enhanced bone fragility and a conse-
quent increase in fracture risk (1). This disease is not as
well studied in men as in women, but older men are also a
large contributor to the burden of fractures. Every third
osteoporotic fracture occurs in men (2), and mortality
after a hip fracture is higher in men than in women (3).
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Areal bone mineral density (aBMD), measured with
dual-energy X-ray absorptiometry (DXA), is currently
the “gold standard” to diagnose osteoporosis and has
been shown to strongly predict fractures (4). Never-
theless, as DXA is a 2-dimensional technique, it gives a
rather crude bone measurement which does not allow
discrimination between the trabecular and cortical bone
compartments or assessment of cortical porosity. A large
proportion of fractures in fact occur in subjects not
identified by low aBMD. In contrast, 3-dimensional
computed tomography (CT)-based techniques have the
capacity to discriminate between these specific bone
parameters. Using CT-based analyses of the tibia, we
have in recent human genetic studies identified specific
loci associated with cortical bone size and density,
cortical porosity, and trabecular bone volume fraction,
strongly suggesting that these bone parameters are
separately regulated (5, 6). In the current study, we
hypothesized that any of these bone parameters, mea-
sured using a CT-based technique, might add in-
formation for fracture prediction beyond DXA-derived
aBMD.
Previous studies using central CT measurements at the
spine or hip followed by finite element analyses have
demonstrated that bone strength calculated at the eval-
uated fracture site predicts incident spine and hip frac-
tures (7–10). However, central CT scans give a higher
radiation dose than peripheral scans and are limited to
the hospital settings. Therefore, it is of importance to
determine if any bone measure from the peripheral CT
scanners, giving limited radiation exposure, has the ca-
pacity to improve fracture prediction beyond aBMD.
With the introduction of high-resolution peripheral
quantitative CT (HR-pQCT; resolution 82 mm), separate
assessments of cortical bone mass, cortical porosity,
cortical area, and trabecular bone volume fraction at
peripheral bone sites has become readily available (11,
12). Previous studies have indicated that a variety of HR-
pQCT-derived bone parameters are associated with
previous fractures (13–16), but no study has investigated
if any HR-pQCT-derived bone parameter predicts in-
cident fractures.
Clinical risk factors such as previous fracture, he-
redity, smoking, and per oral glucocorticoid use predict
fracture risk independently of aBMD (17–20). With the
use of aBMD alone, many patients in need for in-
tervention to prevent future fracture will be missed (13).
To improve the identification of these patients, theWorld
Health Organization introduced the Fracture Risk As-
sessment (FRAX) tool with which clinical risk factors
could be used to estimate the probability of sustaining a
fracture with or without knowing aBMD (21). Evalua-
tion using FRAX with aBMD is nowadays included in
many clinical guidelines, but still, the FRAX tool would
probably be strengthened by the addition of novel
aBMD-independent fracture risk markers.
The overall aim of this study was to investigate if
separate information on cortical and trabecular bone
mass or cortical porosity, measured using HR-pQCT,
predict fracture risk independently of FRAXwith aBMD.
Methods
Subjects and methods
The prospective multicenter study of osteoporotic fractures
in elderly men (MrOS) consists of cohorts from the United
States, Hong Kong, and Sweden (22). The Swedish cohort (23,
24) comprises 69- to 80-year-old Swedish men who were
randomly selected using national population registers, and in-
vited to participate. The 3 Swedish sites had ethical approval
from each corresponding region’s ethical review board for the
prospective multicenter study. The ethical review board in
Gothenburg, Sweden, gave approval for the follow-up study
including the HR-pQCT imaging. All participants gave their
written consent to participate in the complete study including
DXA, HR-pQCT, and x-ray of the spine at both the baseline
and follow-up study. Inclusion criteria included being able to
walk without aid, sign an informed consent, and complete a
questionnaire. The Swedish Gothenburg cohort consists of
1010 men, of which 600 (59.4%) attended the 5-year follow-up
exam. The last 478 men attending the 5-year follow-up exam
underwent HR-pQCT imaging on the distal tibia. Ultimately,
456 men had acceptable image quality of the tibia.
Height and weight were measured with standardized
equipment and information on parameters included in the
FRAX calculations [i.e., previous fracture, parental history of
hip fracture, smoking, use of per oral glucocorticoids, alcohol
consumption, having rheumatoid arthritis, body mass index
(BMI), age, and sex] was collected by a standardized ques-
tionnaire. The prospective study period for assessing incident
fractures was calculated from each study participant’s study
inclusion date (HR-pQCT measurements at the 5-year visit in
MrOSGothenburg study) until either an end point (i.e., fracture
or death) or the end of follow-up period (1 September 2015).
The average follow-up time was 5.3 6 2.0 years. Date of death
was retrieved from the regional administrative patient registry.
Fracture events were obtained using a digital radiology database
consisting of regional patient data (i.e., radiology reports and
corresponding images) from all radiology examinations. The
occurrence of fractureswas cataloged by type into amain group,
consisting of men with any fracture, and a subgroup including
men with major osteoporotic fractures [according to the FRAX
definition (25)]. All men had a spine x-ray available at study
inclusion. The validation of vertebral fracture incidence
included a comparison between the initial x-ray of the spine and
an x-ray conducted during the study period (on clinical in-
dication). All classified fractured vertebraswere normal or had a
minor deformity (,20% anterior to posterior height loss) at
study inclusion, and had a moderate to severe fracture (.25%
height reduction) or a radiology report stating a worsened
vertebral fracture during the study period. Due to the definition
of osteoporotic fracture, skull and face fractures were not in-
cluded (26).
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DXA measurements of aBMD
Measurements of aBMD at the femoral neck (FN-aBMD)
were performed using a Holologic QDR 4500/A-Delphi DXA
(Holologic, Waltham, MA) with a coefficient of variation less
than 3.0%.
HR-pQCT measurements of cortical and trabecular
bone parameters separately
Following a previously described protocol (12), a HR-pQCT
device (XtremeCT; ScancoMedical AG, Bru¨ttisellen, Switzer-
land) was used to measure cortical and trabecular bone pa-
rameters separately at the left distal tibia (or nonfractured leg if
prior fracture). Utilizing a grading scale supported by the
manufacturer, each image was ranked on a scale of 1 (optimum
quality) to 5 (unacceptable). Images with a quality of 4 or 5were
discarded. All scans were analyzed with the manufacturer’s
standard in vivo analysis protocol and processed according to
Laib et al. (27). With this automated threshold-based algorithm
cortical bone was separated from trabecular bone resulting in
the following parameters from both bone compartments, pre-
sented with their corresponding coefficients of variation (CVs):
cortical thickness (mm, 0.3%), cortical area (mm2, 0.4%),
cortical volumetric BMD (g/cm3, 0.1%), trabecular bone vol-
ume fraction (BV/TV; %, 0.3%), trabecular number (mm21,
1.6%), trabecular thickness (mm, 0.7%), and trabecular sep-
aration (mm, 1.4%). Additional parameters obtained were the
mean cortical perimeter (mm, 0.1%; i.e., the mean length of the
periosteal circumference). The cortical bone mineral content
(cortical bone mass) was calculated as cortical area 3 cortical
density and is given as mg/mm cortical bone. With an extended
cortical bone analysis, incorporated in a customized version of
the manufacturer’s Image Processing Language (IPL v5.08b
Scanco Medical AG), cortical porosity was assessed according
to a previously described method (28). The CV for cortical
porosity measured at the tibia was 5.5%. The main bone pa-
rameters evaluated in this study included (a) a general size
measurement of cortical area, (b) an overall measure of cortical
bone mass (cortical bone mineral content), (c) a measure of the
cortical bone quality as reflected by cortical porosity (19), and
(d) an overall measure of the amount of trabecular bone given as
trabecular bone volume fraction. The cortical bone mass pa-
rameter corresponds to the frequently used pQCT parameter
bone mineral content (29).
Finite element analysis of calculated mechanical
strength
Microfinite element models of the tibia were created directly
from the segmented HR-pQCT images to estimate failure load
in compression. This was made by a finite-element software
(version V5.11/FE-V01.15), incorporated in the analysis soft-
ware provided by Scanco. To estimate failure load each bone
voxel tissue was converted into an equally sized brick element
(30) and all bone materials were given a Young modulus of 10
GPa and a poisson ratio of 0.3 as reported by Pistoia et al. (31).
The estimated failure load (N) was computed as earlier de-
scribed (31), and the failure load is calculated based on the
assumption that fracture occurs when 2% of the bone elements
surpass the critical limit of 7000 microstrains. The microfinite
element analyses also report bone stiffness (kN/mm). CVs for
the obtained variables were 0.2% to 0.3%.
Statistical analysis
Differences in anthropometrics, covariates, and bone vari-
ables (aBMD and HR-pQCT parameters) were examined using
independent samples t test for continuous variables between
men with and without fracture. Cox proportional hazard
models were used to evaluate associations between bone pa-
rameters and incident fracture. From these models, a composite
variable was built, based on the beta estimates (from the Cox
models) of age, BMI, and femoral neck aBMD in combination
with either cortical area or cortical bone mass. The constructed
composite variables were then compared with the variable only
containing femoral neck aBMD, age, and BMI using receiver
operating characteristic curve analysis. We further compared
different models by using the net reclassification improvement
(NRI) and integrated discrimination improvement (IDI) indices
to assess the improvement in risk prediction over base models
containing (a) age and BMI or (b) the major osteoporotic
fracture FRAX parameter with aBMD (32, 33). To identify the
proportion of subjects correctly reclassified by adding either
cortical area or cortical bone mass as an extra predictor, the
incremental discriminative ability of cortical area or cortical
bone mass compared with the base models was assessed by
using category-free NRI, IDI, and relative IDI (after rounding
predicted values to 4 decimal places).
Results
Of the 456men enrolled, 71 (15.6%) sustained 1 or more
incident fractures (any fracture group) during the in
average 5.3-year follow-up period, and 50men suffered a
major osteoporotic fracture (Table 1). Men with any
incident fracture had reduced FN-aBMD (–8.9%), cor-
tical bone mass (–20.0%), cortical area (–17.1%), and
trabecular bone volume fraction (–8.6%), whereas cor-
tical porosity was unchanged compared with men with
no fracture (Table 2).
Cortical area and bone mass measured using
computed tomography predict fracture risk
We first evaluated if any of the main separate CT
parameters, cortical bone mass, cortical area, cortical
porosity, or trabecular bone volume fraction, predicted
fracture risk. In Cox proportional hazard models ad-
justed for age and BMI, cortical bone mass was a robust
[hazard ratio (HR) per standard deviation (SD) decrease,
2.07; 95% confidence interval (CI), 1.58 to 2.70] as well
as cortical area (HR per SD decrease, 2.05; 95%CI, 1.58
to 2.65) and trabecular bone volume fraction a moderate
(HR per SD decrease, 1.61; 95% CI, 1.26 to 2.07) pre-
dictor of any fracture risk (Table 3). Similar associations
were seen when major osteoporotic fractures were
evaluated separately (Table 3). When cortical area or
cortical bone mass were included together with trabec-
ular bone volume fraction in the same age and BMI-
adjusted Cox model, cortical area and bone mass (HR
1.87; 95% CI, 1.41 to 2.48, and 1.88; 95% CI, 1.40 to
518 Ohlsson et al Cortical Bone Area Predicts Incident Fracture J Clin Endocrinol Metab, February 2017, 102(2):516–524
Downloaded from https://academic.oup.com/jcem/article-abstract/102/2/516/2972084
by Australian Catholic University user
on 06 August 2018
2.51, respectively), but not trabecular bone volume
fraction, was independently associated with any fracture
risk. The proposed cortical bone quality measure cortical
porosity did not significantly predict fracture risk
(Table 3).
Calculated mechanical strength parameters stiffness
and failure load both moderately predicted fracture risk
(Table 3). However, after additional adjustment for
cortical area (stiffness: HR 1.34; 95% CI, 0.99 to 1.79,
and failure load: 1.35; 95% CI, 1.01 to 1.81) only failure
load remained a significant predictor of any fracture. In
contrast, adjusting for cortical bone mass, both strength
measures remained significant (HR 1.36; 95%CI, 1.02 to
1.81 and 1.37; 95% CI, 1.03 to 1.83, respectively).
We next determined if cortical area, cortical bonemass
or the other HR-pQCT derived predictors (in Table 3)
predicted fractures independently of the “gold standard”
clinically used DXA-derived bone parameter FN-aBMD.
Cortical area and cortical bone mass predict fracture
risk independently of aBMD
Importantly, the association of cortical area and
cortical bone mass with any fracture risk remained es-
sentially unaffected after further adjustment for FN-
aBMD (area: HR 1.91; 95% CI, 1.39 to 2.63) and
(mass: HR 1.94; 95%CI, 1.39 to 2.71; Table 4). Cortical
area (HR 1.96; 95% CI, 1.44 to 2.66) and cortical bone
mass (HR 1.99; 95% CI, 1.45 to 2.74) were robust in-
dependent predictors of any fracture risk in models ad-
justed for FRAX with femoral neck aBMD (Table 4).
Similar aBMD- and FRAX- independent associations for
cortical area and cortical bone mass were observed when
major osteoporotic fracture risk was evaluated (Table 4).
Adding any of these bone traits to FN-aBMD and
covariates resulted in a higher area under the curve (Fig.
1). Cortical density, trabecular BV/TV, and the bone
strength measures (stiffness and failure load) all predicted
any fracture and MOF moderately and independently of
Table 1. Number of Each Type of Incident Fracture
Any
Fracture
Major
Osteoporotic
Vertebral 22 22
Hip 14 16
Humerus 7 6
Wrist and forearm 6 5
Femur (avulsion fracture) 1 1
Rib 9 —
Pelvis 2 —
Patella 1 —
Hand and fingers 3 —
Shoulder and clavicle 3 —
Ankle 2 —
Foot and toes 1 —
Number of fractures used in the Cox proportional hazard models is
presented for each individual according to location of the fracture and
fracture category.
Em dash indicates no incident fracture for the corresponding fracture type.
Table 2. Extended Baseline Characteristics
All Subjects
(N = 456)
No Fracture
(n = 385)
Any Fracture
(n = 71)
Age (years) 80.2 6 3.5 80.2 6 3.5 79.8 6 3.4
BMI (kg/m2) 25.9 6 3.2 25.9 6 3.2 25.7 6 3.3
FN-aBMD (g/cm2)a 0.78 6 0.13 0.79 6 0.13 0.72 6 0.13**
FRAX score with FN-aBMD (%)a 9.6 6 5.4 9.2 6 4.6 12.6 6 8.3***
HR-pQCT
Cortical bone parameters (n = 456) (n = 385) (n = 71)
Cortical bone mass (mg/mm) 95.2 6 34.0 98.3 6 33.2 78.6 6 33.5***
Cortical area (mm2) 120 6 35 123 6 34 102 6 35***
Cortical thickness (mm) 0.99 6 0.31 1.02 6 0.30 0.84 6 0.32***
Cortical perimeter (mm) 122 6 9 122 6 9 123 6 9
Cortical density (mg/cm3) 779 6 75 784 6 74 750 6 76***
Cortical porosity (%) 11.8 6 4.1 11.7 6 4.1 12.2 6 4.0
Trabecular bone parameters (n = 456) (n = 385) (n = 71)
Trabecular bone mass (BV/TV %) 14.9 6 2.8 15.1 6 2.8 13.8 6 2.7***
Trabecular number (mm21) 1.97 6 0.30 1.98 6 0.30 1.91 6 0.33
Trabecular thickness (mm) 76.0 6 11.6 76.6 6 11.4 72.8 6 12.0*
Trabecular separation (mm) 0.44 6 0.08 0.44 6 0.08 0.47 6 0.09*
FEA calculated mechanical strength (n = 450) (n = 380) (n = 70)
Stiffness (kN/mm) 240 6 46 244 6 45 219 6 43***
Failure load (kN) 12.2 6 2.2 12.3 6 2.2 11.2 6 2.0***
Variables are presented as mean6 SD, and statistical differences were investigated with an independent samples t test. FRAX score is shown as a 10-year
fracture probability given for major osteoporotic fracture with FN-aBMD. *P , 0.05; **P , 0.01; ***P , 0.001.
Abbreviation: FEA, finite element analyses.
an = 405, as FN-BMD was not available in all subjects.
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FN-aBMD and FRAX score. These analyses reveal that
cortical area and cortical bone mass were the strongest
predictors of fracture risk independently of aBMD and
FRAX with aBMD.
Cortical bonemass improves fracture reclassification
Finally, we evaluated if cortical area or cortical bone
mass improved fracture reclassification as evaluated by
NRI and IDI. Addition of cortical area or cortical bone
mass both to a base model of age and BMI and to a base
model of FRAX with aBMD resulted in significant im-
provements of NRI (Table 5). The improved combined
NRIs were the result of both a correct upward reclassi-
fication of those with a fracture and a correct downward
reclassification of those without a fracture (Table 5). The
probability change for any fracture as determined by IDI
was also significantly improved by adding cortical area or
cortical bone mass to a base model of FRAX with aBMD
Table 3. Association Between Multiple HR-pQCT Variables and Incident Fractures
Any Fracture
(n = 456/71)
MOF Fracture
(n = 456/50)
DXA
FN-aBMD (g/cm2)a 1.88 (1.34–2.62) 2.79 (1.83–4.25)
HR-pQCT
Cortical bone parameters
Cortical bone mass (mg/mm) 2.07 (1.58–2.70) 2.46 (1.78–3.40)
Cortical area (mm2) 2.05 (1.58–2.65) 2.34 (1.73–3.16)
Cortical thickness (mm) 1.96 (1.51–2.54) 2.26 (1.65–3.08)
Cortical perimeter (mm) 0.84 (0.66–1.07) 0.78 (0.58–1.04)
Cortical density (mg/cm3) 1.71 (1.38–2.12) 1.83 (1.45–2.32)
Cortical porosity (%) 1.15 (0.92–1.45) 1.22 (0.94–1.59)
Trabecular bone parameters
Trabecular bone mass (BV/TV; %) 1.61 (1.26–2.07) 1.90 (1.41–2.57)
Trabecular number (mm21) 1.23 (0.95–1.60) 1.27 (0.93–1.74)
Trabecular thickness (mm) 1.51 (1.18–1.94) 1.84 (1.36–2.47)
Trabecular separation (mm) 1.28 (1.03–1.61) 1.35 (1.04–1.75)
FEA calculated mechanical strength (n = 450/70) (n = 450/49)
Stiffness (kN/mm) 1.66 (1.37–2.01) 1.84 (1.49–2.27)
Failure load (kN) 1.68 (1.38–2.04) 1.86 (1.50–2.31)
Values are presented as HRs with 95% CIs per SD decrease (cortical bone mass, cortical area, cortical thickness, cortical perimeter, cortical density,
trabecular bonemass, trabecular number, trabecular thickness, stiffness, and failure load) or SD increase (cortical porosity and trabecular separation). Cox
proportional hazardmodels were used to investigate the associations, and significant results are presented in bold. Themodels were adjusted for age and
BMI.
Abbreviation: FEA, finite element analyses.
an = 405, as FN-BMD was not available in all subjects.
Table 4. Bone and Strength Parameters Predict Fractures Independently of DXA aBMD
Base Model
Any Fracture MOF Fracture
[N = 456 (n = 71)] [N = 456 (n = 50)]
Cortical bone mass (mg/mm) Age, BMI, FN-aBMD 1.94 (1.39–2.71) 2.16 (1.46–3.19)
FRAX with FN-aBMD 1.99 (1.45–2.74) 2.43 (1.68–3.53)
Cortical area (mm2) Age, BMI, FN-aBMD 1.91 (1.39–2.63) 2.00 (1.39–2.87)
FRAX with FN-aBMD 1.96 (1.44–2.66) 2.27 (1.61–3.20
Cortical density (mg/mm3) Age, BMI, FN-aBMD 1.65 (1.28–2.13) 1.61 (1.23–2.12)
FRAX with FN-aBMD 1.74 (1.36–2.21) 1.81 (1.39–2.34)
Trabecular bone mass (BV/TV; %) Age, BMI, FN-aBMD 1.39 (1.01–1.90) 1.39 (1.01–1.90)
FRAX with FN-aBMD 1.46 (1.09–1.96) 1.46 (1.09–1.96)
Stiffness (kN/mm) Age, BMI, FN-aBMD 1.49 (1.15–1.93) 1.49 (1.15–1.93)
FRAX with FN-aBMD 1.52 (1.20–1.93) 1.52 (1.20–1.93)
Failure load (kN) Age, BMI, FN-aBMD 1.50 (1.14–1.96) 1.50 (1.14–1.96)
FRAX with FN-aBMD 1.53 (1.19–1.95) 1.53 (1.19–1.95)
Values are presented as HRs with 95% CIs per SD decrease. Number of subjects with fractures are given within parenthesis. Cox proportional hazard
models were used to investigate the associations. In models adjusted for FN-aBMD as measured by DXA, 405 subjects are included (55 any fracture; 41
MOF fractures).
Abbreviation: MOF, major osteoporotic fracture.
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(Table 5). These reclassification improvements were also
reflected by the relative IDI (Table 5). Similar significant
improvements of NRI and IDI were observed for major
osteoporotic fractures when either cortical area or cor-
tical bone mass was added to a base model of FRAXwith
aBMD (Table 5). Thus, the reclassification parameters
NRI and IDI were significantly improved when either
cortical area or cortical bone mass was added to FRAX
models with aBMD.
Discussion
Although aBMD, measured using 2-dimensional DXA,
is a robust and clinically useful predictor of fracture
risk, it cannot determine the cortical and trabecular
bone compartments separately or analyze the cortical
porosity, requiring 3-dimensional HR-pQCT analyses.
This study is the first prospective study evaluating the
associations between these parameters, as assessed by
HR-pQCT, and fracture risk. We, herein, demonstrate
that cortical area and cortical bone mass were in-
dependently of aBMD associated with fracture risk and
that fracture reclassification was significantly improved
when either of these bone parameters were added to
FRAX models with aBMD.
Several CT-based techniques exist for 3-dimensional
analyses of the human skeleton including central CT (hip
or spine), standard-resolutionpQCT (resolution@500mm),
Figure 1. Receiver operating characteristic curves for a composite variable constructed from age, BMI, femoral neck bone mineral density, and
(A) cortical area or (B) cortical bone mass compared with femoral neck bone mineral density combined with age and BMI. AUC, area under
the curve.
Table 5. Reclassification for Fracture Using Cortical Area or Cortical Bone Mass
Base Model
Reclassification NRI (95% CI) Probability Change IDI (95% CI)
Combined Event Nonevent Combined Event Nonevent Relative IDI
Any fracture
Age and BMI + cortical area 0.60 (0.35–0.86) 0.35 0.25 0.06 (0.03–0.08) 0.05 0.01 14.69
FRAX with FN-aBMD + cortical area 0.54 (0.25–0.82) 0.27 0.26 0.03 (0.01–0.05) 0.02 0.00 0.57
Age and BMI + cortical bone mass 0.61 (0.36–0.87) 0.41 0.21 0.06 (0.03–0.08) 0.05 0.01 14.22
FRAX with FN-aBMD + cortical bone
mass
0.61 (0.33–0.89) 0.38 0.23 0.03 (0.01–0.04) 0.02 0.00 0.54
MOF fracture
Age and BMI + cortical area 0.73 (0.44–1.02) 0.44 0.29 0.06 (0.04–0.09) 0.05 0.01 5.42
FRAX with FN-aBMD + cortical area 0.76 (0.43–1.08) 0.41 0.34 0.03 (0.01–0.06) 0.03 0.00 0.46
Age and BMI + cortical bone mass 0.73 (0.44–1.03) 0.48 0.25 0.06 (0.04–0.09) 0.06 0.01 5.50
FRAX with FN-aBMD + cortical bone
mass
0.71 (0.38–1.03) 0.41 0.29 0.03 (0.01–0.06) 0.03 0.00 0.45
Bold indicates significant improvement in reclassification.
Abbreviation: MOF, major osteoporotic fracture.
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and high-resolution pQCT (resolution 40 to 82 mm).
Previous studies using central CT measurements revealed
that bone strength measures from finite element analyses
at the evaluated fracture site predict fracture risk (7–10).
However, central CT scans give a higher radiation dose
than peripheral scans and are limited to the hospital
settings.
One previous study with limited statistical power,
including 39 men with incident fractures during an av-
erage follow-up of 2.9 years, evaluated the association
between bone parameters measured by a standard res-
olution pQCT and nonvertebral fracture risk (34). The
authors used non-hypothesis-driven principal component
analyses of as many as 58 different pQCT parameters in
search of a bone parameter to be selected for subsequent
studies of fracture discrimination. These broad analyses
indicated that bone strength measurements of the radius
might add information beyond aBMD for fracture pre-
diction but the significance thresholdwas not adjusted for
the multiple testing of as many as 58 parameters (34).
In the current study, we used HR-pQCT, providing a
detailed separation of the trabecular and cortical bone
compartments and also ameasure of cortical bone porosity.
So far, this fairly new technique has only been used to
investigate the association with prevalent fractures, re-
vealing significant associations for a variety of HR-pQCT
derived parameters (13–16). To avoid multiple testing, the
present prospective study was hypothesis driven. Based on
our previous human genetic findings that separate loci were
identified as determinants of cortical bone size and density
(mass), trabecular bone volume fraction, and cortical po-
rosity (5, 6), we hypothesized that any of these principally
distinct bone measures might add information beyond
aBMD for fracture prediction. When evaluating 456 men,
of whom 71 sustained an incident fracture during the av-
erage follow-up of 5.3 years, we, herein, clearly demon-
strated that tibial cortical bone area and bone mass were
both aBMD-independent predictors of fracture risk. Im-
portantly, addition of these bone traits to FRAX models
with aBMD revealed that reclassification was significantly
improved as a result of both a correct upward reclassifi-
cation of those with a fracture and a correct downward
reclassification of those without a fracture.
This observed association between cortical bone mass
and incident fracture in the current study risk can be
expected as cortical bone comprises more than 80% of
the skeleton and is proposed to be the major contributor
to overall fracture risk (35). It is also obvious that the
2-dimensional technique DXA cannot give a true specific
estimate of cortical bone mass, whereas this bone pa-
rameter can be accurately and specifically determined by
the 3-dimensional technique HR-pQCT. We believe this
is the reason why cortical bone mass, measured by HR-
pQCT, adds information beyond aBMD, measured by
DXA, for fracture prediction. Although HR-pQCT
measurements may not be used in clinical practice due
to high costs related to the procedure, we propose that
simpler and less expensive single slice pQCT could be
used in the clinic to measure cortical area and cortical
bone mass.
The lack of significant association between cortical
porosity, a measure of cortical bone quality, and incident
fractures in the current study is in contrast to some
previous cross-sectional studies suggesting that cortical
porosity is associated with fractures (13, 14, 36). This
discrepancy might be due to a lack of statistical power in
our study, insufficient algorithms, or scan resolution for
the accurate determination of cortical porosity and/or the
fact that cortical porosity may only have a modest impact
on fracture risk. Additional well-powered prospective
studies are required to determine if cortical porosity also
might add information beyond aBMD and cortical bone
mass for fracture prediction.
The current study has limitations. Peripheral CT scans
do not analyze the actual bone site of the most important
osteoporosis fractures, and, therefore, the site-specific
bone parameters from peripheral CT scans might be
less informative. In addition, all fractures included in the
current study have been used regardless of trauma se-
verity. The quality of the HR-pQCT images obtained at
the tibia was low for 18 men and therefore these men
could not be included in the present analyses. Our cohort
included only men, all of whom were older than 75 years
and most of whom were white. Additional studies are
therefore required to confirm these results for other co-
horts of men and women.
The study also has strengths. MrOS Sweden is a well-
characterized, population-based cohort of older men. It
is the first prospective study investigating the association
between HR-pQCT–derived bone parameters and
fracture risk. In addition, all fractures that were included
in the study were x-ray verified. The study participants
were carefully characterized at baseline, including
measures of FN-aBMD by DXA and distal tibia HR-
pQCT scans. The availability of both 2-dimensional and
high resolution 3-dimensional measures of bone pa-
rameters enabled a unique comparison of the associa-
tion of aBMD and HR-pQCT-derived parameters with
incident fractures.
In conclusion, cortical area and cortical bone mass
predict fracture risk independently of aBMD in older
men. We propose that HR-pQCT measurement of
either cortical area or the composite trait of cortical
bone mass might add clinically useful information to
improve the identification of individuals at high risk for
fracture.
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